Zobrazeno 1 - 10
of 43
pro vyhledávání: '"K. Kätkä"'
Autor:
J. Jouppila, Juhani Vilpo, E. Järvenpää, M. Kááriáinen, C. Wasastjerna, Heikki Hallman, Allan Rajamäki, A. Hänninen, G. Järventie, D. Nyman, Erkki Elonen, J. Savola, I. P. Palva, S. Pakkala, Tapani Ruutu, K. Soininen, B. Isomaa, T-T. Pelliniemi, P. Nyländen, E. Koivunen, T. Oivanen, H. Mäkelä, K. Kätkä, Reino Lahtinen, T. Pulli, M. Lehtinen, A. Laitinen, A. Almqvist, Tuomo Timonen, H. Kilpi, K. Ala Harja, P. Ahrenberg, M. Ilvonen
Publikováno v:
European Journal of Haematology. 44:121-124
94 patients with refractory multiple myeloma were treated in a multicentre trial with combinations of cytotoxic drugs including anthracyclines. All were refractory to a 5-drug combination containing 3 alkylating agents, vincristine and methylpredniso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6c38882c057c4fbd001103386004e76
https://doi.org/10.1111/j.1600-0609.1990.tb00362.x
https://doi.org/10.1111/j.1600-0609.1990.tb00362.x
Autor:
Pirjo Koistinen, H. Kilpi, S. Rosengård, M. Lehtinen, Ala-Harja K, M. Ilvonen, T. Pulli, B. Isomaa, R. Lahtinen, A. Laitinen, Liisa Volin, C. Wasastjerna, E. Koivunen, T. Oivanen, T. Timonen, A. Rajamäki, H. Mäkelä, K. Kätkä, D. Nyman, A. Almqvist, G. Järventie, I. P. Palva, K. Soininen, E. Järvenpää, Juhani Vilpo, Erkki Elonen, Kari Remes, Tarja-Terttu Pelliniemi, A. Hänninen, Tapani Ruutu, Heikki Hallman, P. Nyländen, J. Jouppila, M. Kááriáinen
Publikováno v:
European Journal of Haematology. 51:98-101
In a randomised multicentre trial a combination of methylprednisolone, vincristine, lomustine, cyclophosphamide and melphalan (MOCCA) was compared with the same regimen omitting methylprednisolone after the first course (COLA) in previously untreated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5854540015d91707b04f947f16f00756
https://doi.org/10.1111/j.1600-0609.1993.tb01600.x
https://doi.org/10.1111/j.1600-0609.1993.tb01600.x
Autor:
Heikki Hallman, I. P. Palva, H. Mäkelä, E. Koivunen, A. Hänninen, T. Oivanen, K. Kätkä, J. Apajalahti, J. Tiilikaninen, Reino Lahtinen, Tuomo Timonen, M. Ilvonen, E. Järvenpää, Tarja-Terttu Pelliniemi, T. Pulli, Ala-Harja K, Juhani Vilpo, H. Kilpi, G. Järventie, P. Ahrenberg, E. Korpi, M. Lehtinen, S. Rosengård, E. Waris, A. Almquist, C. Wasastjerna, S. Koistinen, A. Laitinen, A. Rajamäki
Publikováno v:
Scandinavian Journal of Haematology. 35:205-209
A one-armed multicentre trial was conducted in Finland during the period from Jan. 1979 to Feb. 1980 to document the possible beneficial effect of aggressive combination chemotherapy MOCCA on the remission induction and survival in multiple myeloma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f71c05df3bfb736e26950266f7f37379
https://doi.org/10.1111/j.1600-0609.1985.tb01574.x
https://doi.org/10.1111/j.1600-0609.1985.tb01574.x
Publikováno v:
Scandinavian Journal of Haematology. 36:412-413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8d972a42d932d64f81c21d06d434c77
https://doi.org/10.1111/j.1600-0609.1986.tb01760.x
https://doi.org/10.1111/j.1600-0609.1986.tb01760.x
Autor:
E. Koivunen, A. Almqvist, H. Kilpi, K. Ala-harja, K. Soininen, K. Kätkä, C. Wasastjerna, Ilmari Palva, P. Ahrenberg, J. Jouppila, H. Hallman, A. Hävninen, E. Järvenpää, H. Mäkelä, E. Waris, P. Nyländen, S. Koistinen, A. Laitinen, T. Pijlli, Reino Lahtinen, M. Ilvonen, B. Isomaa, T. Oivanen
Publikováno v:
Leukemia & Lymphoma. 2:127-129
The actual use of hospital beds for patients with multiple myeloma was calculated from a randomised trial of primary treatment with either melphalan and prednisone (MP, 66 patients) or intensive combination chemotherapy with vincristine, cyclophospha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e57cfcc6f913088987508b1cd5d150
https://doi.org/10.3109/10428199009042522
https://doi.org/10.3109/10428199009042522
Autor:
R. Lahtinen, Pekka Vuopio, Liisa Volin, C. Wasastjerna, E. Koivunen, T. Oivanen, T. Timonen, A. Rajamäki, K. Kätkä, A. Almqvist, G. Järventie, I. P. Palva, Juhani Vilpo, Erkki Elonen, Kari Remes, Tarja-Terttu Pelliniemi, A. Hänninen, Tapani Ruutu, J. Jouppila
Publikováno v:
European journal of haematology. 47(3)
108 consecutive patients with de novo acute myeloid leukaemia at ages 15 to 59 years were treated in a prospective controlled multicentre trial. Induction with combination TAD resulted in a complete remission in 85 cases (79%). After a cyclic consoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479904831dfc3e18360daf482b53ef8f
https://pubmed.ncbi.nlm.nih.gov/1915807
https://pubmed.ncbi.nlm.nih.gov/1915807
Autor:
E, Soppi, J, Viikari, K, Kätkä, T T, Pelliniemi, L, Aalto-Setälä, V, Antila, S, Jalava, E, Kaarsalo, J, Koskelainen, S, Laurila
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 102(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a01a215b7b6609ece40a5c54ab8ec27
https://pubmed.ncbi.nlm.nih.gov/3081320
https://pubmed.ncbi.nlm.nih.gov/3081320
Publikováno v:
Bone marrow transplantation. 3(5)
Allogeneic bone marrow transplantation offers a new and promising form for treatment of multiple myeloma incurable with chemotherapy. We present four cases of advanced multiple myeloma given bone marrow transplantation from HLA-identical and MLC-nega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ac9cd68fb9c338d2fa83ba6d6ba0e69
https://pubmed.ncbi.nlm.nih.gov/2973361
https://pubmed.ncbi.nlm.nih.gov/2973361
Autor:
A, Toivanen, J, Nikoskelainen, E M, Lilius, T T, Salmi, K, Kätkä, T T, Pelliniemi, A L, Mäki, A, Rajamäki
Publikováno v:
Transplantation proceedings. 19(1 Pt 3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e03df6b305dcbaf85d99ac1a39cdd612
https://pubmed.ncbi.nlm.nih.gov/3079095
https://pubmed.ncbi.nlm.nih.gov/3079095
Publikováno v:
Clinical immunology and immunopathology. 46(1)
Three pernicious anemia (PA) patients with selective IgA deficiency and anti-IgA antibodies in their sera were followed for over 3 years. After instituting therapy with cyanocobalamin there was a slight increase in the anti-IgA antibodies. After 1 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53a31d65312123512c4df8af725d937
https://pubmed.ncbi.nlm.nih.gov/3257178
https://pubmed.ncbi.nlm.nih.gov/3257178